As of 2026-03-23, the Relative Valuation of Jounce Therapeutics Inc (JNCE) is (19.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.88 USD, the upside of Jounce Therapeutics Inc based on Relative Valuation is -1121.4%.
The range of the Relative Valuation is (18.19) - (21.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 21.7x | 18.6x |
| Forward P/E multiples | 18.8x - 23.7x | 21.1x |
| Fair Price | (18.19) - (21.01) | (19.20) |
| Upside | -1067.4% - -1217.6% | -1121.4% |
| Date | P/E |